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Background: Strongyloides stercoralis can undergo an alternative autoinfective life cycle in the host, which, in some
individuals can lead to a lethal infection. However, due to a number of factors, such as, the majority of those
infected are from low-income backgrounds and the limitation in experimental models for studying human S. stercoralis,
strongyloidiasis remains neglected. Improved knowledge of animal models that are susceptible to this parasite is
needed in order to investigate the immunological mechanisms involved during infection and in particular to further
understand the natural history of the autoinfective cycle.
Methods: Callithrix penicillata were inoculated subcutaneously with 100 (n = 2), 300 (n = 4) or 500 (n = 9) third-stage
infective larvae (L3i) of S. stercoralis of human origin. Three marmosets received smaller inocula (i.e., one received 100
and two received 300 L3i) to ensure a greater capacity to withstand the infection after immunosuppression, which was
triggered by administration of dexamethasone during early patency. Qualitative faecal analyses began at 7 days
post-infection (DPI), and semi-quantitative tests were also performed for the dexamethasone-treated primates and the
three matched controls. During the necropsies, specimens of S. stercoralis were recovered and tissue fragments were
processed for histopathology.
Results: The mean prepatency and patency periods were 16.1 ± 3.0 and 161.1 ± 72.2 DPI, respectively. The marmosets
typically tolerated the infection well, but immunosuppressed individuals exhibited higher numbers of larvae in the
faeces and progressive clinical deterioration with late disseminated infection. In these cases, the number of females
recovered was significantly higher than the number of inoculated L3i. Large quantities of larvae were observed
migrating through the host tissues, and histopathology revealed pulmonary and intestinal injuries consistent with
those observed in human strongyloidiasis.
Conclusions: Both complicated and uncomplicated strongyloidiasis occur in C. penicillata that is described as a
susceptible small non-human primate model for S. stercoralis. This host permits the maintenance of a human strain of
the parasite in the laboratory and can be useful for experimental investigations of strongyloidiasis. In parallel, we discuss
data related to the autoinfective cycle that provides new insights into the biology of S. stercoralis.
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Strongyloides stercoralis (Bavay, 1876), which is the main
aetiological agent of human strongyloidiasis, is the only
medically important nematode that can multiply in the
host via an autoinfective cycle to reach critical levels and
cause death [1-3]. A number of factors, such as the major
involvement of low-income individuals and residents of de-
veloping countries [1,4,5], limitations for proper diagnosis
(e.g., up to 70% of cases are not detected by conventional
methods [6]) and the absence of viable models for the
study of S. stercoralis of human origin, have contributed to
making strongyloidiasis a neglected disease; although
strongyloidiasis has been known since the nineteenth cen-
tury and has a wide geographical distribution, this disease
remains neglected, with estimates indicating that this infec-
tion currently affects at least 370 million people around
the world [4]. However, a recent meta-analysis conducted
using data from several countries indicates that even this
number may be underestimated [5]; this study reported
that in the People’s Republic of China alone, the average
prevalence of strongyloidiasis might reach 14% (i.e.,
approximately 200 million cases).
The relative lack of interest in this infection among
the research community has generated discussion as to
whether strongyloidiasis is the most neglected of the
neglected tropical diseases (NTDs) [2]. Even the World
Health Organization (WHO) failed to include strongyl-
oidiasis in its original list of 17 NTDs, although this
helminthiasis is now one of the seven “other neglected
conditions” together with chronic suppurative otitis media,
scabies, snakebites, mycetoma, nodding syndrome and
podoconiosis [7]. Concern about strongyloidiasis has aug-
mented, possibly due to the increasing number of fatal
cases, including patients who die due to iatrogenic causes
related to the inappropriate use of immunosuppressive
drugs [8-11]. Complicated strongyloidiasis (i.e., hyperinfec-
tion and/or dissemination of S. stercoralis) often occurs
during host immunosuppression, particularly during pro-
longed high-dose corticosteroid treatment, which is the
main risk factor for disseminated disease [12,13]. In a
recent review of clinical cases of complicated strongyloid-
iasis, 67% (164/244) of patients had received corticoste-
roids [11].
The lack of available direct experimental evidence has
led to the discussion of interesting immunological
factors involved in S. stercoralis dissemination during
human strongyloidiasis in patients with immunosuppres-
sion caused by treatment with corticosteroids or by in-
fection with the Human Immunodeficiency Virus (HIV)
or Human T-Lymphotropic Virus type 1 (HTLV-1). The
immunosuppression induced by viruses and by the
administration of this class of drug is similar because the
immunological activity of the organism is affected pri-
marily by interference with cell-mediated immunity[14-16]. Differences in the immunology of the HIV and
HTLV-1 viruses in the host explain the increased num-
ber of cases of disseminated strongyloidiasis in patients
with prior HTLV-1 infection. HIV infection usually
results in reduced T helper cell type 1 (Th1) responses,
while T helper cell type 2 (Th2) responses are unaffected
or even increased [17]. In contrast, individuals infected
with HTLV-1 exhibit a predominantly Th1 response
[17,18]. During human co-infection with S. stercoralis
and HTLV-1, increased production of interferon-γ
(IFN-γ) and interleukin-10 (IL-10) is associated with de-
creased production of interleukin 5 (IL-5) by peripheral
blood mononuclear cells (PBMCs). In addition, reduced
levels of immunoglobulin E (IgE) are observed. These
findings indicate a change from a Th2 to Th1 response
[19]. The modulation of the immune response that is in-
duced by IFN-γ produced by activated T cells in patients
harbouring HTLV-1 has been suggested to cause reduced
serum IgE levels [20]. PBMCs from individuals infected
with both S. stercoralis and HTLV-1 also exhibit reduced
production of interleukin-4 (IL-4). Even after elimination
of S. stercoralis by ivermectin treatment, lower blood IgE
levels and eosinophil counts were observed in these
patients than in patients infected with only S. stercoralis
[21]. Investigations performed in both humans and
experimental models with different species of intestinal
nematodes demonstrated that the production of immuno-
globulins and Th2 cytokines is beneficial to the host. IL-4
and IL-5 stimulate the migration of eosinophils and IgE
production, which play a central role in mast cell degranu-
lation, preventing parasite attachment and invasion of the
host intestinal mucosa. In addition, the increased fre-
quency and intensity of peristaltic waves can contribute to
the expulsion of intestinal nematodes [9,22,23]. Eosino-
phils and antibodies participate in human immunity
against S. stercoralis larvae and are likely to reduce the risk
of developing severe forms of the disease because im-
munoglobulin levels and eosinophil numbers were signifi-
cantly lower in patients with complicated disease than in
patients with uncomplicated disease [24]. Additionally, the
occurrence of both humoral and cellular responses, with
increases in mast cell numbers and histamine levels in the
host intestinal mucosa, was previously demonstrated in
patas monkeys (Erythrocebus patas) infected with a hu-
man strain of S. stercoralis [25-27]. The mechanisms re-
lated to S. stercoralis dissemination in patients receiving
corticosteroids are not yet fully known. Among the vari-
ous effects induced by corticosteroid treatment during dif-
ferent pathological processes, reduced expression of pro-
inflammatory cytokines, chemokines, adhesion molecules
and enzymes related to inflammation has been reported
[14,28]. These drugs also affect the number and character-
istics of circulating cells in the vertebrate host and the mi-
gration of leukocytes to the site of infection [29-31]. The
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apoptosis in immune cells, including lymphocytes and eo-
sinophils, can also occur [14,30,32]. Furthermore, al-
though the effects of corticosteroids on the host immune
system are significant, some evidence suggests that the
Th2 response may be more affected by treatment than the
Th1 response; in these cases, a consequent reduction in
the number and activity of eosinophils and mast cells is
related to the dissemination of S. stercoralis [9,27,33].
Moreover, an alternative hypothesis has been proposed to
explain the occurrence of complicated strongyloidiasis. Al-
though this hypothesis is not yet experimentally con-
firmed, it suggests that endogenous or exogenous
corticosteroids may share structural similarities with
nematode ecdysteroids. As a result, corticosteroids may
favour molting of rhabditiform larvae, resulting in a sub-
stantial increase in the number of infective larvae of S.
stercoralis that have the ability to penetrate the host intes-
tinal mucosa (i.e., auto-infection) [34].
Experimental studies of S. stercoralis, particularly those
related to complicated strongyloidiasis, are needed to
obtain a better understanding of this infection and facili-
tate the development of new strategies for the preven-
tion and treatment of human disease. Even aspects of
the basic biology of S. stercoralis, such as the replication,
development and migration of this pathogen in the host,
requires further investigation. Mice typically do not
support the development of S. stercoralis [35]. The use
of jirds (Meriones unguiculatus) to study the parasite has
limitations, such as the lack of available immunological
information for these rodents and the small number of
larvae that are released in the faeces of these rodents,
which makes it difficult to maintain S. stercoralis in the
laboratory [36]. The canine model, which was used in
early experimental studies of strongyloidiasis [37,38],
was popular in the 1980s and 1990s and provided inter-
esting results from experiments using nematode strains
isolated from dogs [39-45] and humans [46-49]. However,
when dogs were experimentally infected with human
isolates of S. stercoralis, a reduction in the prepatency of
infection and an abolition of the hyperinfection process
and any type of extra-intestinal migration of the parasite,
including during immunosuppression, were observed after
a small number of passages in the new host [49]. The ex-
tremely variable susceptibility of dogs to Strongyloides spp.
[37,38,50,51] is considered the main drawback of the
canine model, but the large phylogenetic distance between
dogs and humans, practical difficulties related to the size
of these animals and high housing and maintenance costs
have also restricted the use of this model [46].
A non-human primate model is desirable because, in
addition to the phylogenetic proximity and physiological
similarities between humans and other primates, stron-
gyloidiasis cases with clinical and pathological featuressimilar to those observed in human disease, including
fatalities, have been reported in gibbons [52], orangutans
[53], gorillas and chimpanzees [54]. Captive patas mon-
keys also presented fatal strongyloidiasis [55], and this
observation stimulated the previously described studies
[25-27] using a human isolate of S. stercoralis in this pri-
mate; however, the large size of this potential model and
practical difficulties impede wider use of this model. The
use of marmosets as a nonhuman primate model is a
viable alternative due to the small size and easy handling
of these Neotropical primates. Indeed, we have already
suggested Callithrix penicillata as a model for the study
of strongyloidiasis [56], but the infecting parasite species
was Strongyloides venezuelensis.
The infection of marmosets with human S. stercoralis was
standardized in this study, and the natural history of com-
plicated (i.e., after immunosuppression using dexametha-
sone) and uncomplicated strongyloidiasis are reported. The
data obtained illustrate that the use of marmosets as a
model for the study of strongyloidiasis is promising, includ-
ing for studies of various aspects of disseminated infection
after the administration of corticosteroids. Additionally,
new considerations related to the biology of the nematode,
particularly with respect to its development and migration
within the host, are discussed.
Methods
Nonhuman primates
Fifteen adult male specimens of captive-born C. penicillata
that weighed 370 ± 45 g and were reared in the marmoset
colony in the Instituto de Ciências Biológicas (ICB) at the
Universidade Federal de Minas Gerais (UFMG) were se-
lected for experimental study. Briefly, in this colony, small
families of marmosets are kept in different rooms (1 m
wide, 3 m long, and 2.5 m high) for breeding. These
nurseries have brick walls, a roofed section and another
section bounded by an iron grid at the top to allow direct
exposure to sunlight. The marmosets do not have eye
contact with the adjacent room. Food is distributed twice
per day: fruit in the morning and a feed ration ad libitum
in the afternoon [57]. When necessary the morning feed is
replaced by egg yolks or gelatin containing a multivitamin
supplement [58].
The specimens used in the present study were placed in
individual cages that each had a PVC tube suspended near
the top, providing a nest for the marmosets to rest and
hide. The animals remained housed in the cages through-
out the period when the experiments were conducted, and
the clinical state of the animals was checked every day.
Considerations for experimental design
This study included two experiments related to strongyloid-
iasis in C. penicillata. Experiment I aimed to accomplish
the standardization of primary infection. All marmosets
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were considered in this study. Experiment II aimed to
assess the effect of immunosuppression induced by cortico-
steroids on experimental infection. Among the 15 animals
infected with the parasite, three received immunosuppres-
sive therapy using dexamethasone and three others were
matched as untreated controls (see below).
Parasites
The strain of S. stercoralis used in this study was isolated
from human faecal material from individuals living in
the state of Minas Gerais, Brazil. The strain was main-
tained in the laboratory by means of successive passages
in marmosets.
Obtaining and counting the infective larvae
To obtain infective third-stage filariform larvae (L3i),
faecal cultures were set up. Faeces from humans or mar-
mosets were mixed with vermiculite and then incubated
in a chamber heated to 27°C for a period of between 48
and 72 hours. Recovery of the larval forms was made
using the Baermann method, as modified by Moraes [59],
and the suspension containing L3i were decontaminated
according to Martins et al. [60]. Aliquots of 25 μl were
collected with the aid of an automated pipette and were
placed as drops on slides for counting to be performed.
The mean number was calculated from evaluations on at
least three aliquots, and the suspension was then diluted
or concentrated in order to attain a final concentration of
100, 300 or 500 L3i in 0.5 ml of distilled water.
Infection of the marmosets
Each marmoset was infected by means of subcutaneous
inoculation of 0.5 ml of a suspension containing L3i of
S. stercoralis obtained from human (H) or marmoset
(M) faecal cultures. Animals P1 and P2 (n = 2) and P3
and P4 (n = 2) were inoculated with 100 and 500 L3i/H,
respectively. The other marmosets received 100 (i.e., P5
and P6; n = 2), 300 (i.e., P7 and P8; n = 2) and 500 (i.e.,
P9, P10, P11, P12, P13, P14 and P15; n = 7) L3i/M.
Dexamethasone administration
Three primates (i.e., P2, P6 and P8) received short-term
treatment with 2.5 mg/kg of dexamethasone (Decadron®)
subcutaneously for five consecutive days, starting the 4th
(P6 and P8) or 5th (P2) week post-infection [56]. This
drug is a glucocorticoid with a known immunosuppres-
sive effect. Treated and control primates were matched
according to weight and the source and number of
inoculated L3i. These animals received a lower number
of L3i (i.e., 100 or 300) to ensure that they could
tolerate the infection and to model the potential for
complicated disease for a longer period of time after
immunosuppression.Coproparasitological examination
Beginning one week after infection, fresh samples of
faeces from all of the marmosets were collected 5 days
per week throughout the period of the experiment in
order to make qualitative analyses using the spontan-
eous sedimentation [61] and modified Baermann [59]
methods. Approximately 2 g of stool was processed for
the first technique, and faecal cultures were started
with the remainder of the samples for use in the latter
method. For the spontaneous sedimentation technique,
3 slides were analyzed per day and all of the material
obtained using the Baermann-Moraes method was ex-
amined. Examinations of each animal’s faecal samples
were performed until parasitological cure (i.e., after at
least 12 consecutive weeks in which the samples exhib-
ited negative faecal results).
For the marmosets used in experiment II, a semi-
quantitative estimation of the number of nematode forms
in the immunosuppressed and control groups was con-
ducted during spontaneous sedimentation assays [62] that
were performed until 10 weeks of infection. Because the
amount of faeces used in these assays and the volume ana-
lyzed on each slide were approximately constant, positive
results were categorized by convention as + (< 10 L1 per
slide), ++ (10 to 100 L1 per slide) and +++ (> 100 L1 per
slide) by the same author.
Necropsy, recovery of S. stercoralis and histopathology
The primates that spontaneously died and the marmoset
P4 that was euthanized were necropsied. The intestines
of these animals were opened longitudinally in Petri
dishes containing a 0.85% solution of sodium chloride.
After scraping the intestines using a glass slide, the pres-
ence of larvae and parasitic females of S. stercoralis in
the host tissues was directly evaluated using a stereo-
microscope. The samples were transferred to a sieve that
was placed on sedimentation glass containing saline and
incubated at 37°C for three hours. Nematodes were
recovered from the sediment, counted and fixed in 10%
formalin. We also searched for specimens of S. stercoralis
in other organs, including the lungs, liver, spleen and
kidneys.
Parasitic females were classified according to the cri-
teria described by Faust [63]. The juvenile female has a
vulva that is already evident, but its total length does not
exceed 1.5 mm, which is shorter than the total length of
adult females. The ratio “esophagus length/total length”
(approximately 1/3) is intermediate between the ratios
observed in L3i (1/2) and adult females (1/4), while the
tail (i.e., the distance between the anus and the posterior
end) is proportionally longer in juvenile females.
Small fragments of intestines and other organs were
fixed in 10% neutral buffered formalin, and the tissues
were subsequently paraffin-embedded, cut into 4-μm
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histopathological slides were captured using a Leica
DM500 microscope (Leica Microsystems, Heerbrugg, St.
Gallen, Switzerland) with a video camera attached to a PC.
Statistical analysis
The Shapiro-Wilk test was used to determine normality.
Data was analysed using a Student’s t-test when the dis-
tribution was Gaussian and the Kruskal-Wallis test was
used when the distribution was non-parametric.
Ethics
The use of marmosets in this biomedical research study
was authorized by the Instituto Brasileiro do Meio
Ambiente e Recursos Naturais Renováveis (IBAMA), and
the experimental procedures were conducted in accord-
ance with the precepts of the local animal research ethics
committee of UFMG (CETEA/CEUA) (registration num-
ber of the ethical authorization 167/06, renewed in 2012).
Results
The marmoset model is susceptible to a human isolate of
Strongyloides stercoralis
Marmosets were susceptible to S. stercoralis, irrespective of
the number (i.e., 100, 300 or 500) and origin (i.e., human
or marmoset) of inoculated L3i. The infection of C. penicil-
lata was confirmed by the presence of the parasite in
faeces and/or in necropsies (Tables 1, 2; Figure 1). Most
infected marmosets (86.7%, 13/15) released rhabditiform
larvae of S. stercoralis in their faeces. Marmosets P11 and
P14, who died before the patent period, were exceptions.
However, in these animals, specimens of S. stercoralis and/
or tissue lesions induced by the parasite were observed.
No significant differences in the natural course of infec-
tion were observed among immunocompetent primates
infected with different numbers of L3i, except for some
deaths that occurred during early infection in marmosetsTable 1 Percentage of parasitic females recovered after inocu
Callithrix penicillata
Primates Days post-infectio










p - valueinfected with 500 L3i (see subtopic on lethality). More-
over, the origin of the L3i (i.e., from human or marmoset
faecal cultures) also failed to influence the evaluated
parameters. The mean prepatent and patent periods were
16.1 ± 3.0 and 161.1 ± 72.2 days post-infection (DPI),
respectively. Rhabditiform larvae of S. stercoralis were first
observed during faecal analysis of marmosets at a mini-
mum of 13 (P4 and P13) and a maximum of 22 DPI (P9).
Early (P13) and late (P10) parasitological cures were
observed at 70 and 308 DPI, respectively (Figure 1).
Reproducibility of the clinical forms of human
strongyloidiasis in immunocompetent and
dexamethasone-immunosuppressed experimental hosts
Strongyloidiasis in marmosets was representative of ob-
servations of human infection with S. stercoralis. Based
on the evaluation of parasitological and anatomo-clinical
parameters, the two forms of human disease that occur
in the presence and absence of immunosuppression were
also observed in experimentally infected marmosets.
I. Uncomplicated strongyloidiasis
In the absence of exogenous immunosuppression in-
duced by dexamethasone administration, most specimens
of C. penicillata tolerated the infection with S. stercoralis
well, particularly after established patency. In addition to
supporting the complete development of the parasite, the
immunocompetent marmosets exhibited signs of intestinal
strongyloidiasis, with outcomes representative of those
observed in immunocompetent humans infected with the
nematode.
II. Complicated strongyloidiasis
The animals inoculated with dexamethasone exhib-
ited reversible adverse signs related to treatment withlation of infective larvae of Strongyloides stercoralis into
n % of infective larvae of S. stercoralis recovered as parasitic females
Small intestine Large intestine Other organs Total
21.6 (108/500) 2.2 (11/500) 0 23.8 (119/500)
15.8 (79/500) 1.6 (8/500) 0 17.4 (87/500)
10.6 (53/500) 0 (0/500) 0 10.6 (53/500)
16.0 ± 5.5 1.3 ± 1.1 0 17.3 ± 6.6
719.0 (719/100) 18.0 (18/100) 10.0 (10/100) 747.0 (747/100)
613.0 (613/100) 37.0 (37/100) 7.0 (7/100) 657.0 (657/100)
156.0 (468/300) 3.0 (9/300) 11.7 (35/300) 170.7 (512/300)
496.0 ± 299.2 19.3 ± 17.0 9.6 ± 2.4 524.9 ± 310.5
< 0.05 < 0.005 < 0.05
Table 2 Results of a semi-quantitative faecal analysis in immunocompetent and dexamethasone-immunosuppressed
marmosets during experimental strongyloidiasis
Primates Untreated (uncomplicated strongyloidiasis) Treated with dexamethasone (complicated strongyloidiasis)
P1 P5 P7 P2 P6 P8
L3i Number 100 100 300 100 100 300
Source H M M H M M
Days post-infection
1 to 7 - - - - - -
8 to 14 + - - - - -
15 to 21 + + + + +* +*
22 to 28 + + + + + + +* + +
29 to 35 + + + + + + + + + + + +
36 to 42 + + + + + + + + + +
43 to 49 + + ++ + + + + + + + +
50 to 56 + + + + + + + + + +
57 to 63 + + - + + + + + + + + +
64 to 70 + + - + + + + +
71 to 77 + + + + + + + +
78 to 84 + + + + +
85 to 91 + + - + +
92 to 98 + + - +
99 to 105 + - - +**
L3i = inoculated infective larvae.
H = human.
M =marmoset.
+, ++, +++ indicate low, moderate, and high numbers of larvae in the faeces, respectively, and - indicates a negative result.
*Course of dexamethasone treatment.
**Dead at 109 days post-infection.
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cating immunosuppression during and after the admin-
istration of the drug. However, the main changes in the
natural course of infection were observed later, culmin-
ating in the typical scenario of hyperinfection followed
by dissemination of S. stercoralis and death of the host.
Characteristics of complicated and uncomplicated
strongyloidiasis in marmosets
Parasitological faeces analysis
An alternation between positive and negative results
was observed during uncomplicated infection in pri-
mates. Long periods of serial positive tests and serial
negative tests were observed. The largest continuous
periods of positive (25 weeks) and negative (four weeks)
results were observed in marmosets P1 and P10,
respectively. During the patent period, negative faecal
analyses became proportionately more common for
most untreated animals as the duration of infection
progressed (Figure 1). However, the group that received
dexamethasone exhibited no negative parasitological
results during the patent period of the infection and a
greater number of larvae of S. stercoralis was observedin the stools of these animals than in the stools of the
animals in the control group (Table 2). Slides of faecal
material from immunosuppressed marmosets showed
full fields of parasite larvae under light microscopy,
particularly in the last weeks before the death of each
animal. In the days preceding the death of the animal
P8, faecal analyses were impossible due to a lack of
evacuation.Lethality
The overall lethality rate observed among the marmosets
in the first weeks of experimental strongyloidiasis, prior
to treatment of primates with dexamethasone, was 20%
(3/15). The proportion of deaths was affected by the
number of inoculated L3i. All deaths of untreated mar-
mosets occurred early in infection in animals that re-
ceived 500 L3i parasites (at 3, 12 and 21 DPI for P11,
P14 and P3, respectively). Moreover, when considering
only this initial period prior to the third week after L3i
inoculation, the lethality among marmosets infected with
500 L3i of S. stercoralis was 33.3% (3/9) and the lethality
was 0 (0/6; also including the three animals that were
Figure 1 Results of faecal analyses of Callithrix penicillata during experimental infection with Strongyloides stercoralis. Each week, faecal
material from the marmosets that corresponded to at least five different days was evaluated and analyses were performed until confirmation of
parasitological cure or death of the primate. L3i = inoculated infective larvae, H = human, M =marmoset, DEX = dexamethasone treatment.
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lated with 100 or 300 L3i.
In experiment II, the lethality of S. stercoralis infec-
tion in dexamethasone-treated marmosets was 100%
(3/3) and the lethality was zero (0/3) in the respective
controls (Figure 1, Table 2). It is worth noting that
unlike the deaths of untreated animals, the primates
who received the immunosuppressive regimen and
developed complicated strongyloidiasis died later in
infection, between 4 and 12 weeks after the administra-
tion of the drug.
In total, 7 necropsies were performed, corresponding
to the 6 primates who died spontaneously due to stron-
gyloidiasis and the euthanized animal P4.Clinical and pathological aspects
The mean weight of the primates with uncomplicated
disease did not vary significantly over the natural course
of strongyloidiasis. However, in marmosets with the
complicated form of infection, a reduction of adipose
tissue and an average loss of weight of 28% (p < 0.05)
occurred gradually and steadily until the time of death.
Although most immunocompetent primates infected
with S. stercoralis appeared healthy during the experi-
ment, signs such as bristling fur, respiratory effort/dys-
pnea and appetite loss were observed, particularly early
in the infection (i.e., during the pulmonary phase of
larval migration). Subsequently, gastrointestinal manifes-
tations emerged; these manifestations included diarrhea,
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periods of constipation. A gradual clinical improvement
then occurred in the animals that healed spontaneously,
despite varying temporal evolution. The marmosets that
received dexamethasone exhibited more severe clinical
manifestations due to hyperinfection and dissemination
of the parasites. Prior to the deaths of these animals, in
addition to intestinal manifestations, the late involvement
of the respiratory system was observed. In particular, in
marmoset P2, the nervous system was also affected.
Histopathology revealed sections of adults and larvae of
S. stercoralis in the intestinal mucosa of primates (Figure 2).
Similar to the semiologic and lethality findings, the path-
ology also varied depending on the presence or absence of
prior immunosuppressive treatment with dexamethasone.
The organs involved and the characteristics and intensity
of the microscopic lesions were dependent on the time
elapsed from infection to necropsy.
Lung injuries in untreated C. penicillata, such as inter-
stitial pneumonitis, hyperemia, oedema, thromboembol-
ism and alveolar hemorrhage, were observed during
periods corresponding to the primary pulmonary migra-
tion of S. stercoralis, and basophilic structures were ob-
served in the alveolar lumen in marmoset P11, which died
at 3 DPI. In the small intestine, the presence of an inflam-
matory infiltrate consisting primarily of mononuclear cells
was observed in the lamina propria. In restricted areas, in-
volvement of the submucosa, with changes in the struc-
ture of the villi, particularly atrophy, was observed during
uncomplicated strongyloidiasis. However, in animals with
S. stercoralis dissemination, pulmonary lesions similar toFigure 2 Histological section of the small intestine of Callithrix penicil
the parasitic elements in the mucosa and the detachment of villi. HE stain.those described above were observed, but these lesions
had a late onset and occurred to a greater extent. Further-
more, severe enteritis, with a mononuclear cell inflamma-
tory infiltrate that was mixed with polymorphonuclear
cells in some areas and reached the deeper layers of the
organ, was observed. Areas of complete destruction of
villi, with erosions and ulcerations, hyperemia and oedema
of the submucosa and subserosa were observed. Odema-
tous colitis related to larval migration was another com-
mon finding.Recovery of larvae and parasitic females of S. stercoralis
In all necropsied marmosets, excluding the primate that
died at 3 DPI, parasitic females of S. stercoralis were
found, primarily in the host small intestine. The mean
percentage recovery of parasitic females from untreated
primates was 17.3 ± 6.6% of the total inoculated L3i. In
dexamethasone-treated marmosets, this value reached
524.9 ± 310.5% (p <0.05) and was significantly higher.
Surprisingly, the number of recovered S. stercoralis
females was more than 7 times the L3i inoculum in mar-
moset P2 (Table 1). The immunosuppressed marmosets
whose deaths were related to the dissemination of the
nematode harboured similar total numbers of parasitic
females (512, 657 and 747 in P8, P6 and P2, respectively)
regardless of the number of larvae inoculated (i.e., 100
or 300 L3i). An average of 638.7 ± 118.6 parasitic females
were recovered from these 3 primates; in contrast, this
value was much lower (86.3 ± 33) among primates who
did not receive dexamethasone.lata experimentally infected with Strongyloides stercoralis. Note
Bar = 200 micrometers.
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tent and immunosuppressed marmosets and juvenile
females of S. stercoralis were observed in their intestines,
even during more advanced infection periods. The
proportion of juvenile parasites in the small intestine in
untreated marmosets was small, but the absolute num-
ber was similar to the mean quantity of parasitic females
observed in the large intestines. This number is propor-
tionally higher than the number of S. stercoralis females
observed in the same organ in marmosets with compli-
cated disease. However, the number of S. stercoralis
parasitic females in the large intestine of marmosets that
exhibited a severe form of infection failed to increase
with the same ratio (Table 1, Figure 3).
During necropsies of immunocompetent C. penicillata,
a small number of filariform larvae of S. stercoralis were
found migrating in the intestines and more rarely in the
lungs (i.e., one larva in one animal). Most of the larvae
observed in these primates were rhabditiform and were
primarily found free in the gut lumen. Conversely, in all
immunosuppressed marmosets, variable forms of S. ster-
coralis (i.e., mostly rhabditiform and infective larvae but
also juvenile and adult parasitic females) were recovered
from the intestines and from extraintestinal sites such as
the stomach, trachea and lung, liver, gallbladder and extra-
hepatic biliary tract, heart, kidney and spleen (Table 3). A
total of 4,652 specimens of S. stercoralis of different devel-
opmental stages were analyzed, and the mean percentages
of rhabditiform larvae, filariform larvae, juvenile females
and adult females were 19.7%, 39.1%, 13.1% and 28.1%,
respectively. Even in cases of disseminated infection, the
intestines contained the greatest number of S. stercoralis
larvae and females among the evaluated organs. Consider-
ing the distribution of only larval forms among these sameFigure 3 Cumulative number of parasitic females of Strongyloides ste
penicillata according to the degree of development (i.e., juvenile or a
DEX = previous treatment with dexamethasone, L3i = inoculated infective laorgans, a small percentage of parasites was found in
the trachea and lungs, with a similar value to that ob-
served in the liver (Figure 4). The muscles and the skin
were not routinely assessed, however, approximately 500
larvae were found in a fragment of skin and appendages
(approximately 1.5 cm2) from a specimen with eczema
(P8), this is of interest.Discussion
The inability to maintain S. stercoralis of human origin
in the laboratory and the nearly complete absence of viable
models for the study of auto-infection, hyperinfection
and dissemination of this parasite have hampered our un-
derstanding of various aspects related to the biology and
pathophysiology of this parasite. Marmosets are susceptible
to infections with a number of parasites of medical import-
ance [64-70], and the use of these animals has advantages
over other non-human primates: smaller size (i.e., weight
of only approximately 400 g), greater abundance of some
species in nature, ease of captive breeding and handling,
reduced maintenance costs and a relatively lower risk for
the transmission of zoonoses to humans [56,64,71,72]. In
this study, specimens of C. penicillata were susceptible to
infection with S. stercoralis and complicated and uncompli-
cated disease occurred, confirming that these primates are
a promising model for studying strongyloidiasis [56].
The infection that occurred in dexamethasone-untreated
marmosets was representative of the intestinal strongyloid-
iasis that occurs in immunocompetent patients, in which a
balance in the host-parasite relationship occurs, with
absent or minimal auto-infection. Immunosuppressed pri-
mates exhibited changes in the host-parasite relationship
that resulted in S. stercoralis dissemination, as observed inrcoralis recovered from the small and large intestines of Callithrix
dult) and the location. SI = small intestine, LI = large intestine,
rvae; DPI = days post-infection.
Table 3 Number of larvae and females of Strongyloides stercoralis recovered from different organs in three specimens
of Callithrix penicillata that died due to parasite dissemination after dexamethasone treatment










P2 L1 and L2 0 94 84 5 1 6 7 197
L3 and L4 5 415 230 7 1 18 20 696
Juvenile ♀ 2 269 4 1 0 1 2 279
Adult ♀ 0 450 14 2 0 1 1 468
Total 7 1,228 332 15 2 26 30 1,640
P6 L1 and L2 2 99 63 2 0 2 12 178
L3 and L4 17 197 106 4 0 9 11 344
Juvenile ♀ 2 211 12 1 0 1 0 227
Adult ♀ 2 402 25 1 0 0 0 430
Total 23 909 206 8 0 12 21 1,179
P8 L1 and L2 16 217 245 14 0 9 40 541
L3 and L4 15 478 212 10 0 20 45 780
Juvenile ♀ 7 79 4 2 0 7 6 105
Adult ♀ 8 389 5 3 0 0 2 407
Total 46 1,163 466 29 0 36 93 1,833
Mean L1 and L2 6.0 136.7 130.7 7.0 0.3 5.7 19.0 305.3
L3 and L4 12.3 363.3 182.7 7.0 0.3 15.7 25.3 606.7
Juvenile ♀ 3.7 186.3 6.7 1.3 0 3.0 2.7 203.7
Adult ♀ 3.3 413.7 14.7 2.0 0 0.3 1.0 435.0
Total 25.3 1,100.0 334.8 17.3 0.6 24.7 48.0 1,550.7
*Pelvic and other abdominal tissues and organs.
L1 and L2 = rhabditiform larvae of the first and second stages.
L3 and L4 = filariform larvae of the third and fourth stages.
♀ = parasitic female.
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both of the forms of strongyloidiasis that were observed in
C. penicillata are consistent with valuable information
related to human infection. In humans there is a broad
spectrum of clinical symptoms and infected individuals can
be asymptomatic or present severe and fatal forms of the
disease as a result of S. stercoralis dissemination, which is
commonly observed when host immunity is impaired
[1,2,8,73]. Although most animals resisted experimental
strongyloidiasis, during early infection, some marmosets
inoculated with a higher number of L3i died. This point
of infection was critical; in addition to these deaths, more
significant clinical manifestations were observed. Over
time, the immunocompetent marmosets began to better
tolerate the infection, and clinical status improved, with no
new deaths. This finding suggests that a more balanced
host-parasite relationship occurs as the infection becomes
chronic, perhaps due to host immunomodulation. How-
ever, when dexamethasone was administered, fatal cases
occurred in all marmosets that had been infected with
fewer L3i than the respective controls, which progressed to
spontaneous healing.The current understanding that a relationship exists
between complicated strongyloidiasis and reduced host
cellular immunity was first suggested nearly 50 years ago
in independent studies that linked parasite dissemination
to the occurrence of lymphoma [74] and corticosteroid
therapy [75,76]. Today, immunosuppression events,
which often occur due to treatment with corticosteroids,
are associated with an increased risk of disseminated
disease [11-13,73]. The reduction of cellular immunity is
indeed a major cause of complicated strongyloidiasis,
and experimental and natural hosts demonstrated that
the production of Th2 cytokines and immunoglobulins
is necessary to balance the host-parasite relationship and
to eliminate intestinal nematodes [9,22,23,73,77-79]. The
concept that treatment with corticosteroids favours
hyperinfection and the dissemination of S. stercoralis in
humans is based on the fact that although endogenous
and exogenous steroids interfere with different immuno-
regulatory pathways during strongyloidiasis [14,32,80],
these drugs affect the Th2 response more directly [81,82],
increasing the apoptosis of Th2 cells and damaging the
function of eosinophils and mast cells [9,27,33]. Moreover,
Figure 4 Percentage of Strongyloides stercoralis larvae recovered from different organs in three specimens of Callithrix penicillata that
died due to parasite dissemination after dexamethasone treatment. L1 and L2 = rhabditiform larvae of the first and second stages; L3 and
L4 = filariform larvae of the third and fourth stages.
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ively than the production of IFN-gamma in T-cells by
dexamethasone; this finding may account for the selective
outgrowth of Th1-like T cells that was observed in vivo in
patients treated with corticosteroids [82]. In addition to
the host immune system, which may also be impaired due
to iatrogenesis related to pharmacological immunosup-
pression, other potential determinants of severe strongyl-
oidiasis that must be considered include conditions of
reduced intestinal transit, co-infections, aspects related to
hygiene and the nutritional state of the host and the pres-
ence of a high parasite burden associated with an active
auto-infection process [83].
Data on the number of S. stercoralis females recovered
from the intestines of marmosets during experimental
complicated or uncomplicated strongyloidiasis and the
evaluation of the developmental degree (i.e., juvenile or
adult) and location (i.e., small intestine or large intestine)
of the parasite females improved our understanding of
the dynamics of parasitism. These data suggest a balance
in the host-parasite relationship, with a virtually stable
parasitic burden in immunocompetent hosts, because
the number of nematodes that reach the small intestine
is close to the number of nematodes that are recovered
from the large intestine; this latter group might be easier
for the host to expel. The loss of this balance may berelated to the occurrence of complicated strongyloidiasis.
Consistent with this hypothesis, in the small intestine of
marmosets with S. stercoralis dissemination, in addition to
the number, the ratio of juvenile females to adult females
was significantly higher than that observed in primates
that did not receive dexamethasone. Future studies are
needed to determine whether these previously reported
and/or additional unknown mechanisms are involved in
the dissemination of S. stercoralis in marmosets.
Genta [34] stated that dysregulation is related to the
dissemination of S. stercoralis and that the hypothesis of
host immune control used to explain this phenomenon
is vague because it ignores the possibility that the nema-
tode may play a crucial role in its own regulation. The
ability of the parasite to control its population size could
be affected during the deregulatory process; thus, the in-
testinal numbers of S. stercoralis would grow indiscrimin-
ately until the parasite reached a critical value and killed
the host. Although a direct effect of dexamethasone on
the parasite cannot be ruled out, the data obtained in the
present study indicate that another idea proposed by this
same author (i.e., that corticosteroids administered to the
host might spontaneously accelerate the transformation
of rhabditiform larvae of S. stercoralis in the L3i due to
structural similarities of the drug to natural parasite ecdys-
teroids [34]) is questionable. Because at the time of death
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incontestable evidence indicated parasite dissemination
and all drug had presumably been metabolized by the pri-
mate with enough time elapsed to allow the restoration of
the host immune response, the idea that direct acceler-
ation of the transformation of larvae of S. stercoralis by
corticosteroids administered to the host is the main factor
related to the occurrence of disseminated infection is not
supported by the current results. In addition, infective lar-
vae of the nematode were not usually observed in the fae-
ces of dexamethasone-treated marmosets.
Thus, the occurrence of disseminated infection in mar-
mosets did not occur solely due to effects of dexametha-
sone that were induced during the period of drug
administration. Glucocorticoid administration to marmo-
sets infected with S. stercoralis likely caused a sequence of
events that resulted in inadequate control of parasite
burden, providing a less inhospitable intra-host micro-
environment for the parasite.
The mean percentage of S. stercoralis recovered from
immunocompetent marmosets was higher than those
previously reported for beagle dogs, whose mean recovery
percentages of parasitic females were extremely variable
[45], and jirds [36]; both of these models were experimen-
tally infected with parasites of canine origin. However, the
mean recovery rate of S. stercoralis in C. penicillata may
be even higher because the lowest recovery ratio obtained
for the animal P14 may have been because necropsy was
performed at 12 DPI, when nematode larvae could still be
migrating to the host tissues. In studies using E. patas
infected with a human isolate of S. stercoralis [25-27], no
information about the intensity of parasites was presented
for uncomplicated infection, perhaps because these
animals exhibited hyperinfection and dissemination of the
parasite in the absence of immunosuppressive treatment,
which precludes a proper analysis of the number of para-
sites. Schad et al. [39] previously stated that one of the
advantages of the canine model, which was being
proposed at the time, over the nonhuman primate host E.
patas was the fact that complicated infection in this ani-
mal was not representative of human disseminated stron-
gyloidiasis because the dissemination of S. stercoralis
occurred very rapidly and independently of immunosup-
pressive treatment in the patas monkey. However, this
potential limitation of nonhuman primate models was not
observed in marmosets. In cases of hyperinfection and/or
dissemination of S. stercoralis reported in E. patas and in
dogs after glucocorticoid administration [26,39,40], as well
as in C. penicillata in the current study, the number of
larvae and adult worms recovered from animals with
severe strongyloidiasis far exceeded the number of S. ster-
coralis L3i that was initially inoculated. In contrast, the
increase in the number of parasitic females in the intes-
tines of M. unguiculatus after glucocorticoid treatmentwas comparatively slight, and the number of recovered
adult worms was even lower than the number of L3i used
in the inoculum [36].
In human strongyloidiasis, the release pattern of larvae
in the faeces oscillates widely in infected individuals and
correct diagnosis often requires serial examinations
[84,85]. Autoinfection-related variations in the number
of S. stercoralis females in the host were suggested as an
explanation of this phenomenon [86]. In this study, simi-
lar findings were obtained and auto-infection occurred
even during uncomplicated strongyloidiasis. However,
the most substantial differences in the results of the
qualitative and semi-quantitative parasitological tests
were observed between dexamethasone-treated and
untreated primates. The observation of higher numbers
of females of S. stercoralis in the intestines of immuno-
suppressed hosts may reflect a non-static host-parasite
relationship, in which constant attempts to achieve
balance can result in increased or reduced fecundity of
parasitic females in response to changes in the environ-
ment. Thus, the increased ratio of negative tests in the later
patent period in immunocompetent marmosets may also
be related to a reduction in the reproductive potential of S.
stercoralis females, as sterile worms associated with ovarian
degeneration and embryonation failure were common dur-
ing chronic experimental strongyloidiasis in dogs [45].
In comparison to marmosets, the difficulties caused by
the large size of patas monkeys and beagle dogs make the
use of these animals to study experimental strongyloidiasis
more difficult. However, it is important to note that the
present study used a S. stercoralis strain isolated from
humans. In addition, the origin of L3i (i.e., from cultures
of human or C. penicillata faeces) was not related to
marked changes in the evaluated parameters during stron-
gyloidiasis in marmosets. In addition to the molecular dif-
ferences established between S. stercoralis strains isolated
from dogs and hominids [87] and the variable susceptibil-
ities observed in epidemiological and experimental studies
that used different strains and hosts [37,38,51,88,89],
evidence indicates that biological differences exist between
parasites of human and canine origin. The prepatency of
infection with S. stercoralis of human and canine origin is
different, even when the experimental infection is per-
formed in the same host species [39,46,47,88]. In E. patas
and C. penicillata infected with human isolates the prepa-
tent periods varied between 11 and 20 DPI [26] and
between 13 and 22 DPI, respectively, and are consistent
with the values accepted for human hosts [90]. Further-
more, the maintenance of S. stercoralis by successive pas-
sage among specimens of patas monkeys over four years
did not alter the biology of the parasite, including the pre-
patent period [49]; this finding is similar to observations
made in marmosets during the period in which the iso-
lated strain of S. stercoralis was maintained (i.e., until the
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patency of human isolates of S. stercoralis failed to change
significantly in the nonhuman primates C. penicillata and
E. patas, no reduction of the prepatent period was
detected after several successive passages of a strain of
canine S. stercoralis canine in beagles [39,49]. This finding
suggests that parasites isolated from humans and dogs are
able to better adapt to primates and canids, respectively.
Different isolates of S. stercoralis might also present
peculiarities related to the larval migration route in the
host. This observation provides an alternative explan-
ation for the reduced importance attributed, in contra-
diction to the classical notion [37], to larval migration
through the lungs and trachea in dogs infected with a
strain of S. stercoralis that was isolated and maintained
in beagle dogs [41,44]. Despite substantial differences in
the S. stercoralis migratory route, the methodologies
used in these previous studies, which reached opposing
conclusions, were well designed. In addition to findings
related to the spatial and temporal dynamics of larval
migration in canine hosts that were provided by compart-
mentalized mathematical models [41], the in vivo displace-
ment of radioisotope-labeled L3i was monitored by
scintography in ten-day-old beagles inoculated with the
parasite, and a higher concentration of larvae occurred in
the corresponding area of the abdomen in puppies, rarely
in the thoracic region, between 3 and 6 DPI [44]. However,
the high number of radiolabeled S. stercoralis L3i that was
inoculated (i.e., 100,000/animal, subcutaneously) and the
young age of the dogs, which prevented full development
of the immune system, may have contributed these results.
Despite convincing evidence, as previously discussed [34],
the suggestion that the pulmonary route is not relevant
could find resistance in the clinical setting, where S. ster-
coralis larvae are frequently observed in the bronchoalveo-
lar lavage or sputum of patients with complicated
strongyloidiasis [4,6,91-94]. Conversely, hundreds of para-
site larvae were found in lumps of bloody mucus in the tra-
chea of dogs submitted to tracheotomy before infection
with S. stercoralis [37]. Although in this experiment, para-
site passage to the host respiratory system was demon-
strated and most larvae failed to become adults due to
the physical interruption of the trachea, mild infections
occurred and alternative possibilities for nematode de-
velopment cannot be eliminated. Despite the absence of
a specific experiment evaluating larval migration during
the early phase of infection of marmosets with a human
isolate of S. stercoralis, the lung histopathology of the spe-
cimen that died at 3 DPI revealed structures in the alveo-
lar lumen that suggest that parasite passage to this organ
occurred.
Histopathological findings in the lungs and intestines
during both clinical forms of infection with S. stercoralis
in marmosets were consistent with existing informationfor humans, and the injuries observed during dissemi-
nated strongyloidiasis were usually more severe and
characterized by intense inflammation associated with
erosions and/or ulcerations of the mucosa of the small
(duodenojejunitis) and large (colitis) intestines, with
focal or diffuse hemorrhagic processes in the lungs
[83,95-98]. Similar observations were reported during
the natural infection of nonhuman primates [52,55] and
in experimental infections of patas monkeys [26] and
dogs [40,47,99].
Data obtained related to the developmental stages of S.
stercoralis from marmosets who died due to disseminated
infection corroborate the idea that a deficiency in the
mechanism of expulsion of adult worms associated with a
virtually unlimited number of larvae generated by the
auto-infection process occurs in patients with hyperinfec-
tion or disseminated strongyloidiasis [83]. Moreover, rhab-
ditiform and filariform larvae and juvenile and adult
females of S. stercoralis were found in extraintestinal sites,
particularly in the stomach, lung and liver of marmosets
that presented complicated infection. Although these
findings, which constitute convincing evidence of dissemi-
nated strongyloidiasis, were previously reported in human
and experimental infections [26,39,40,47,83,100], they have
not been discussed in detail. Despite conflicting informa-
tion about the importance of pulmonary migration in pri-
mary infection with S. stercoralis in dogs [34,37,41,44], the
available experimental data related to the migration of
parasite larvae through the host tissues in complicated
strongyloidiasis exhibit greater convergence. In this clinical
form, the parasite larvae migrating in the host tissues do
not focus primarily on the pulmonary route. The results
obtained in dogs indicate that during severe disease, only a
small number of the total larvae are recovered from the
lungs and/or trachea [39,40]; this fact was corroborated in
this study using marmosets. Thus, although larval migra-
tion during hyperinfection and disseminated infection was
not the subject of the study performed by Schad et al. [41],
their suggestion that during primary infection, the pulmon-
ary route of migration is only one of many possible routes
for the nematode to reach the host duodenum becomes
even more relevant in the context of disseminated in-
fection. Particularly with respect to complicated dis-
ease, the observation of S. stercoralis larvae, including
larva currens [101-103], in other organs in the natural
host and the isolation of various stages of the parasite
from different organs of marmosets and a large amount
of larvae from a fragment of skin and surrounding tis-
sues from one specimen in this study support the idea
that parasite larvae can migrate randomly, reaching a
number of peripheral sites in the host.
In this study, in primates who died due to disseminated
infection, juvenile and adult females of S. stercoralis,
including some adult females with eggs in their uteri, were
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large intestine, and in organs outside the digestive tube,
particularly the lungs, trachea and liver. Similar findings
were obtained during necropsies of dogs infected with this
nematode in the absence [37,63] or presence [40,47] of
pharmacological immunosuppression. An idea that was
previously suggested [37,63] and remained unpopular
throughout most of the last century is useful in comple-
menting our understanding of existing reports in the lit-
erature related to the observation of rhabditiform larvae
of S. stercoralis in different host organs, including the
lungs [39,47,96,97,100]. Fülleborn [37] did not mention
the presence of all developmental stages of S. stercoralis in
the lungs of experimentally infected dogs, but he sug-
gested that adult females and rhabditiform larvae observed
in the lungs could begin a new local cycle of the parasite
inside the host (i.e., auto-infection). Later, new evidence
from the same host species indicated that the progeny of
parasitic adult females from the lungs are important for
internal auto-infection [63]. Eggs, rhabditiform and
filariform larvae observed in the bronchioles and other
segments of the airway, oesophagus and stomach were
considered to be products of adult worms located in the
lung parenchyma or in the terminal segments of the tra-
cheobronchial tree. The idea that at least one generation of
S. stercoralis can occur in the host lungs was corroborated
by the observation of adult parasites [84,85,104,105] and
eggs, which are sometimes embryonated, in the lungs and
in the airways of human patients [4,97,98,106]. Further-
more, the observation of 4 apparently fertile parasitic fe-
males of S. stercoralis together with 21 rhabditiform larvae/
g of kidney tissue from an immunosuppressed dog infected
with human nematodes [47] also indicates that the
nematode may produce offspring in organs other than
those of the digestive system. This finding was previ-
ously corroborated in immunosuppressed beagle dogs,
which presented a large number of rhabditiform larvae
and parasitic females in different organs [39]. Thus,
although as a rule, the parasites likely do not reach
maturity in the host lung and produce a new generation
in that organ, this phenomenon does occur. Addition-
ally, during complicated strongyloidiasis, adult females
of S. stercoralis may give rise to new generations of the
parasite in other organs of the host, beyond the intes-
tines and lungs, on a small scale.
Finally, considering the high adaptive capacity of S. ster-
coralis during development, with the parasitic females
reaching sexual maturity in adverse situations and even in
ectopic sites, it seems plausible that during disseminated
infection, as an alternative, some larvae could develop
completely in the host intestines without migrating
through other organs for parasite multiplication within
the host. In fact, the finding that juvenile females of S.
stercoralis (on average, approximately 1/3 of the parasiticforms) are present in the large intestines during compli-
cated strongyloidiasis in marmosets suggests that the
parasite cycle may occur locally. Additional evidence for
this notion was provided by the finding that all of the
developmental stages of the parasitic life cycle were
present in both the small and large intestines of immuno-
suppressed hosts, as already mentioned.
The obligatory passage of S. stercoralis larvae through
the lungs, where the nematode would receive stimuli for
its growth has been questioned in the canine model, as
previously discussed [41,44]. Evidence that the entire
development of some larvae of S. stercoralis occurred in
the intestines of marmosets during disseminated stron-
gyloidiasis was presented in this study. A portion of the
filariform larvae and juvenile parasitic females that were
observed in the small intestines of marmosets may have
originated from the lung via the trachea, larynx, phar-
ynx, esophagus and stomach. However, one should also
consider that there was an unusually high proportion of
juvenile females in the large intestines of C. penicillata
and that these observations regarding the degree of
development of the intestinal parasitic females of S.
stercoralis, in combination with the low numbers of
larvae obtained from the lungs of these primates and
the presence of large numbers of larvae in a skin speci-
men, also indicate that large-scale orderly pulmonary
migration does not occur during complicated experi-
mental strongyloidiasis.
Conclusions
The data obtained in this study illustrated that C. penicil-
lata is a susceptible model for infection with S. stercoralis
of human origin. Both the complicated and uncomplicated
forms of strongyloidiasis that are observed in the natural
host can be reproduced in these nonhuman primates,
making this model useful for the investigation of various
aspects of this infection, such as immunopathology, drug
assays and/or the development of new prophylactic mea-
sures. Successful consecutive passages of a human strain of
S. stercoralis in marmosets indicate that laboratory main-
tenance of this organism is possible, at least long enough
to perform the proposed biomedical experiments. More-
over, as long as the ethical principles were in compliance,
the achievement of a substantial number of larvae and
adult females of nematodes in these animals is relevant for
the production of specific antigens for scientific and diag-
nostic purposes. In parallel, marmosets infected with S.
stercoralis facilitated the collection of additional informa-
tion related to the basic biology of the parasite, providing
new insights into the autoinfective cycle, particularly dur-
ing disseminated infection. In addition to the comments
on the imbalance in the host-parasite relationship induced
by corticosteroids from a parasitological perspective, the
other two main points related to the biology of S.
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direct effect of dexamethasone on the parasite is not re-
quired for its dissemination in the nonhuman primate host
and confirmation that during disseminated infection the
full development of S. stercoralis can occur in the host in-
testines and other organs.
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